Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

# Dr Forbes outlined the symptoms of common STIs, emphasising that some people may have no symptoms, making regular screening essential. Chlamydia symptoms include pain during urination, abnormal ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

To learn more, please visit www.reprievetrial.org.

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

To reduce care disparities and prevent them from exacerbating among people living with HIV who have long COVID, education and ...

Sexually transmitted diseases (STDs), also known as sexually transmitted infections (STIs) or venereal diseases, are infections spread primarily through ...

Why is AIDS a syndrome and not a disease? What is syndrome?Lookman (by SMS) AIDS is the result of untreated HIV (Human Immunodeficiency Virus). Over time, HIV destroys CD4-T white blood cells, ...